Intensity Therapeutics, Inc. Common stock (INTS) Short Interest Ratio & Short Volume → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free INTS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesOwnershipShort InterestSocial Media Intensity Therapeutics, Inc. Common stock Short Interest DataCurrent Short Volume25,800 sharesPrevious Short Volume27,400 sharesChange Vs. Previous Month-5.84%Dollar Volume Sold Short$106,296.00Short Interest Ratio / Days to Cover0.5Last Record DateApril 15, 2024Outstanding Shares13,710,000 sharesFloat Size6,940,000 sharesShort Percent of Float0.37%Today's Trading Volume8,191 sharesAverage Trading Volume13,476 sharesToday's Volume Vs. Average61% Short Selling Intensity Therapeutics, Inc. Common stock ? Sign up to receive the latest short interest report for Intensity Therapeutics, Inc. Common stock and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatINTS Short Interest Over TimeINTS Days to Cover Over TimeINTS Percentage of Float Shorted Over Time Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. Intensity Therapeutics, Inc. Common stock Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202425,800 shares $106,296.00 -5.8%0.4%0.5 $4.12 3/31/202427,400 shares $142,480.00 +87.7%0.3%0.4 $5.20 3/15/202414,600 shares $70,226.00 -84.9%0.2%0.2 $4.81 2/29/202496,500 shares $357,050.00 -3.2%1.2%0.2 $3.70 2/15/202499,700 shares $302,091.00 +41.0%1.2%0.2 $3.03 1/31/202470,700 shares $347,844.00 No Change0.9%0.1 $4.92 INTS Short Interest - Frequently Asked Questions What is Intensity Therapeutics, Inc. Common stock's current short interest? Short interest is the volume of Intensity Therapeutics, Inc. Common stock shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 25,800 shares of INTS short. 0.37% of Intensity Therapeutics, Inc. Common stock's shares are currently sold short. Learn More on Intensity Therapeutics, Inc. Common stock's current short interest. What is a good short interest percentage for Intensity Therapeutics, Inc. Common stock? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.37% of Intensity Therapeutics, Inc. Common stock's floating shares are currently sold short. Is Intensity Therapeutics, Inc. Common stock's short interest increasing or decreasing? Intensity Therapeutics, Inc. Common stock saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 25,800 shares, a drop of 5.8% from the previous total of 27,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Intensity Therapeutics, Inc. Common stock's float size? Intensity Therapeutics, Inc. Common stock currently has issued a total of 13,710,000 shares. Some of Intensity Therapeutics, Inc. Common stock's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Intensity Therapeutics, Inc. Common stock currently has a public float of 6,940,000 shares. How does Intensity Therapeutics, Inc. Common stock's short interest compare to its competitors? 0.37% of Intensity Therapeutics, Inc. Common stock's shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Intensity Therapeutics, Inc. Common stock: Ikena Oncology, Inc. (5.48%), Dyadic International, Inc. (0.92%), Genenta Science S.p.A. (0.02%), Aligos Therapeutics, Inc. (0.87%), Turnstone Biologics Corp. (4.76%), Entera Bio Ltd. (0.31%), Cidara Therapeutics, Inc. (0.18%), Instil Bio, Inc. (0.23%), Elutia Inc. (0.19%), Quince Therapeutics, Inc. (6.21%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Intensity Therapeutics, Inc. Common stock stock? Short selling INTS is an investing strategy that aims to generate trading profit from Intensity Therapeutics, Inc. Common stock as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Intensity Therapeutics, Inc. Common stock? A short squeeze for Intensity Therapeutics, Inc. Common stock occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INTS, which in turn drives the price of the stock up even further. How often is Intensity Therapeutics, Inc. Common stock's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INTS, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Ikena Oncology Short Squeeze Dyadic International Short Squeeze Genenta Science Short Squeeze Aligos Therapeutics Short Squeeze Turnstone Biologics Short Squeeze Entera Bio Short Squeeze Cidara Therapeutics Short Squeeze Instil Bio Short Squeeze Elutia Short Squeeze Quince Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INTS) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe World's First "$20 Trillion Drug?"Behind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlaceMan Who Predicted 2008: “This Will be Worse.”Altimetry